This can be accomplished by depriving cultured cells of a preferred glycolytic substrate (glucose) and substituting it with a substrate for oxidative phosphorylation (galactose) [18], as previously demonstrated in ALS [15] and CMT2A MFN2 R274W [20]. The gene discussed is MFN2; the disease is amyotrophic lateral sclerosis.